Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma

NCT00028886 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

450

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: recombinant interferon alfa
DRUG: cyclophosphamide
DRUG: dexamethasone
DRUG: doxorubicin hydrochloride
DRUG: melphalan
DRUG: thalidomide
DRUG: vincristine sulfate
PROCEDURE: bone marrow ablation with stem cell support
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

Commissie Voor Klinisch Toegepast Onderzoek